Ampco-Pittsburgh Corporation

AP▲

Ampco-Pittsburgh swings to Q2 profit on record orders

Ampco-Pittsburgh reported second quarter 2026 net income of $1.5 million, or $0.07 per share, compared to a net loss of $7.3 million, or $0.36 per share, in the prior year period. Adjusted EBITDA rose 22% to $9.8 million, with margin expanding 240 basis points to 9.5% on net sales of $102.9 million. Customer orders of approximately $144 million were up 50% versus prior year, and backlog grew $39.9 million from the first quarter to $385.4 million. The Air & Liquid segment delivered record results, while the Forged and Cast Engineered Products segment saw adjusted EBITDA increase 15% despite lower sales following the closure of its U.K. facility. Management expects a significantly stronger second half of 2026, citing accelerating demand across power generation, U.S. Navy, and North American roll markets.

AP ▲

The Motley Fool·7dRead more ▾

AP▲

Ampco-Pittsburgh Returns to Profitability in Q2 2026

Ampco-Pittsburgh returned to profitability in the second quarter of 2026, reporting net income of $1.5 million, or $0.07 per share, compared with a net loss of $7.3 million, or $0.36 per share, a year earlier. Adjusted EBITDA rose 22% to $9.8 million, with margins expanding to 9.5% on net sales of $102.9 million. Quarterly orders increased 50% to approximately $144 million, while total backlog rose 12% to $385.4 million, driven by strong demand in power generation, U.S. Navy products, and North American steel markets. Management expects the second half of 2026 to be significantly stronger, though seasonal maintenance and European shutdowns will affect the third quarter.

AP ▲

MarketBeat·15dRead more ▾

Biotech & Genomic Medicine▲impact 4

AstraZeneca tumbles 9% after heart drug trial misses primary endpoint

AstraZeneca shares fell 9% after its Phase 3 CARDIO-TTRansform trial of Wainua, developed with Ionis Pharmaceuticals, failed to meet its primary endpoint in patients with transthyretin-mediated amyloid cardiomyopathy. The study did not show a significant improvement in the composite of cardiovascular mortality and recurrent cardiovascular events versus placebo through 140 weeks. Ionis Pharmaceuticals shares declined 8% on the news. Separately, Ampco-Pittsburgh jumped 14% after reporting first-half 2026 customer orders rose 32% year-over-year to $268 million, driven by strength in both operating segments. Levi Strauss fell 6% despite better-than-expected second-quarter revenue and earnings, as its full-year earnings per share outlook midpoint of $1.49 came in below the $1.51 consensus, with the company assuming 30% U.S. tariffs on Chinese imports and 20% tariffs on imports from the rest of the world remain in place through year-end. MDA Space slid 6% after agreeing to acquire a roughly 70% stake in France-based CLS for €567 million and announcing a C$712 million bought-deal equity offering to help finance the transaction.

AP ▲AZN.LSE ▼IONS ▼LEVI ▼

Biotech & Genomic Medicine ▼

Seeking Alpha·48dRead more ▾

AP2

Zacks highlights Amazon, Walmart, American Express and two micro-caps in latest analyst reports

Zacks Equity Research released new analyst reports on 16 major stocks, including Amazon, Walmart, and American Express, along with micro-cap companies Natural Grocers by Vitamin Cottage and Ampco-Pittsburgh. Amazon's shares have outperformed its industry over the past year, driven by diversification across e-commerce, AWS, advertising, and streaming, though rising capital expenditures for AI infrastructure and increasing debt pose risks. Walmart's shares also outperformed, supported by its omnichannel ecosystem and growing profit drivers like marketplace and advertising, while near-term profitability may be affected by fuel costs and elevated investments. American Express benefited from strong spending growth among younger consumers and returned $2.3 billion to shareholders in the first quarter of 2026, but rising expenses and credit-loss provisions warrant a Neutral rating. Natural Grocers by Vitamin Cottage, a micro-cap with a market capitalization of $765.18 million, showed resilient performance with positive comparable sales and an expanding private-label portfolio, though it faces risks from softer consumer spending on premium organic products. Ampco-Pittsburgh, a micro-cap valued at $162.21 million, is shifting toward higher-value infrastructure markets and benefits from favorable tariff dynamics, but must improve profitability in its core business and manage elevated leverage and asbestos liabilities.

AP AXP NGVC AMZN WMT

Zacks Investment Research·48dRead more ▾

AP▲

Ampco-Pittsburgh Reports 32% Increase in Customer Orders Across Key Segments

Ampco-Pittsburgh announced that customer order activity during the first six months of 2026 totaled approximately $268 million, a 32% increase compared to $204 million in the same period of 2025. The Forged and Cast Engineered Products segment reported $153 million in orders, up 25% year over year, while Air and Liquid Processing recorded $116 million, up 42%. Within Air and Liquid Processing, Buffalo Air Handling secured the largest air handling equipment order in its history during the first half of 2026. CEO Brett McBrayer highlighted the improvement as a reflection of stronger demand across key end markets and effective execution. The stock closed Wednesday at $7.17, down 2.85%, but rose 11.72% to $8.01 in overnight trading.

AP ▲

RTTNews·49dRead more ▾